About the journal
Hematology Reports is an open-access journal published by MDPI AG in Switzerland, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 1,600 CHF. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- MDPI AG
- ISSN
- 2038-8322 · 2038-8330
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,600 CHF
- Articles in DOAJ
- 692
- Declared review time
- 6 weeks
- Declared peer-review model
- other
- Official website
- https://www.mdpi.com/journal/hematolrep
Index listings
- DOAJ · 2010-12-03
- PUBMED · 2010-01-26
- Indexing
- DOAJ · PUBMED
- APC
- 1,600 CHF
- Declared review time (DOAJ)
- 6 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
692
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
6weeks
Works in OpenAlex
666
Last recorded publication year
2026
h-index
30
i10-index
152
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2023-05-02
- Added to DOAJ
- 2010-12-03
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPKP PNPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 99%
- ORCID iDs in current deposits
- 96%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101556723
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Lymphoma Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Hemoglobinopathies and Related Disorders
- Chronic Lymphocytic Leukemia Research
Show all subjects (75)
- Platelet Disorders and Treatments
- Hemoglobinopathies and Related Disorders
- Hemoglobinopathies and Related Disorders
- Multiple Myeloma Research and Treatments
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Multiple Myeloma Research and Treatments
- Hematological disorders and diagnostics
- Viral-associated cancers and disorders
- Multiple Myeloma Research and Treatments
- Blood groups and transfusion
- Retinoids in leukemia and cellular processes
- Platelet Disorders and Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Platelet Disorders and Treatments
- Hematopoietic Stem Cell Transplantation
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- Blood groups and transfusion
- Blood groups and transfusion
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- Complement system in diseases
- Iron Metabolism and Disorders
- Iron Metabolism and Disorders
- Blood transfusion and management
- CNS Lymphoma Diagnosis and Treatment
- Hematopoietic Stem Cell Transplantation
- Blood Coagulation and Thrombosis Mechanisms
- Hemophilia Treatment and Research
- CNS Lymphoma Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- Viral-associated cancers and disorders
- Hematopoietic Stem Cell Transplantation
- Viral-associated cancers and disorders
- Eosinophilic Disorders and Syndromes
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Eosinophilic Disorders and Syndromes
- Hematological disorders and diagnostics
- Complement system in diseases
- Hematological disorders and diagnostics
- Complement system in diseases
- Venous Thromboembolism Diagnosis and Management
- Blood disorders and treatments
- Iron Metabolism and Disorders
- Venous Thromboembolism Diagnosis and Management
- Blood disorders and treatments
- Hemophilia Treatment and Research
- Hemophilia Treatment and Research
- Chronic Myeloid Leukemia Treatments
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- COVID-19 Clinical Research Studies
- Blood disorders and treatments
- Cutaneous lymphoproliferative disorders research
- Cutaneous lymphoproliferative disorders research
- Venous Thromboembolism Diagnosis and Management
- Immune Cell Function and Interaction
- Cutaneous lymphoproliferative disorders research
- Erythrocyte Function and Pathophysiology
- Erythrocyte Function and Pathophysiology
- Immune Cell Function and Interaction
- Autoimmune and Inflammatory Disorders Research
- Retinoids in leukemia and cellular processes
- Retinoids in leukemia and cellular processes
Keywords (DOAJ)
- hematology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ